Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.

We report a patient with peripheral rheumatoid corneal melting who developed a corneal perforation in one eye requiring tectonic keratoplasty. Nine consecutive corneal grafts were rapidly destroyed despite systemic immunosuppression with corticosteroid, cyclophosphamide, azathioprine and cyclosporin...

Full description

Bibliographic Details
Main Authors: Newman, D, Isaacs, J, Watson, P, Meyer, P, Hale, G, Waldmann, H
Format: Journal article
Language:English
Published: 1995
_version_ 1797103525319147520
author Newman, D
Isaacs, J
Watson, P
Meyer, P
Hale, G
Waldmann, H
author_facet Newman, D
Isaacs, J
Watson, P
Meyer, P
Hale, G
Waldmann, H
author_sort Newman, D
collection OXFORD
description We report a patient with peripheral rheumatoid corneal melting who developed a corneal perforation in one eye requiring tectonic keratoplasty. Nine consecutive corneal grafts were rapidly destroyed despite systemic immunosuppression with corticosteroid, cyclophosphamide, azathioprine and cyclosporin A. A rejection episode was observed in one graft before it melted and allograft rejection may have contributed to the destruction of other grafts. Corneal graft survival was ultimately achieved by systemic immunosuppression with the anti-lymphocyte monoclonal antibody, CAMPATH-1H. A single episode of rejection developed in the early post-operative period which was easily reversed by topical corticosteroid. Corneal melting has not recurred and the graft has now remained intact and clear for 24 months. Anti-lymphocyte monoclonal antibodies may therefore provide effective immunosuppression in the treatment of refractory ocular disorders.
first_indexed 2024-03-07T06:21:19Z
format Journal article
id oxford-uuid:f2cdabb2-a4ee-45f6-bc81-585227bf009c
institution University of Oxford
language English
last_indexed 2024-03-07T06:21:19Z
publishDate 1995
record_format dspace
spelling oxford-uuid:f2cdabb2-a4ee-45f6-bc81-585227bf009c2022-03-27T12:06:50ZPrevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f2cdabb2-a4ee-45f6-bc81-585227bf009cEnglishSymplectic Elements at Oxford1995Newman, DIsaacs, JWatson, PMeyer, PHale, GWaldmann, HWe report a patient with peripheral rheumatoid corneal melting who developed a corneal perforation in one eye requiring tectonic keratoplasty. Nine consecutive corneal grafts were rapidly destroyed despite systemic immunosuppression with corticosteroid, cyclophosphamide, azathioprine and cyclosporin A. A rejection episode was observed in one graft before it melted and allograft rejection may have contributed to the destruction of other grafts. Corneal graft survival was ultimately achieved by systemic immunosuppression with the anti-lymphocyte monoclonal antibody, CAMPATH-1H. A single episode of rejection developed in the early post-operative period which was easily reversed by topical corticosteroid. Corneal melting has not recurred and the graft has now remained intact and clear for 24 months. Anti-lymphocyte monoclonal antibodies may therefore provide effective immunosuppression in the treatment of refractory ocular disorders.
spellingShingle Newman, D
Isaacs, J
Watson, P
Meyer, P
Hale, G
Waldmann, H
Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
title Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
title_full Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
title_fullStr Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
title_full_unstemmed Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
title_short Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
title_sort prevention of immune mediated corneal graft destruction with the anti lymphocyte monoclonal antibody campath 1h
work_keys_str_mv AT newmand preventionofimmunemediatedcornealgraftdestructionwiththeantilymphocytemonoclonalantibodycampath1h
AT isaacsj preventionofimmunemediatedcornealgraftdestructionwiththeantilymphocytemonoclonalantibodycampath1h
AT watsonp preventionofimmunemediatedcornealgraftdestructionwiththeantilymphocytemonoclonalantibodycampath1h
AT meyerp preventionofimmunemediatedcornealgraftdestructionwiththeantilymphocytemonoclonalantibodycampath1h
AT haleg preventionofimmunemediatedcornealgraftdestructionwiththeantilymphocytemonoclonalantibodycampath1h
AT waldmannh preventionofimmunemediatedcornealgraftdestructionwiththeantilymphocytemonoclonalantibodycampath1h